Swedish investment firm EQT has emerged as the sole bidder for OmniActive Health Technologies after the company rejected a competing offer from Temasek and Novo Holdings. OmniActive, backed by TA Associates, has a strong position in nutraceuticals and a notable export footprint in the United States, making the sale a key development for the sector.
A Gujarat-based NGO is urging the government to regulate nutraceuticals such as health supplements under drug regulators, not food safety authorities. The group alleges uneven product quality and unregulated pricing, arguing the current framework leaves consumers exposed. If accepted, the proposal could bring tighter standards and more transparent costs for nutraceuticals nationwide.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
